Market Place
Sourcing Support
Astex Pharma Announce Key Data at the 36th EORTC-NCI-AACR Symposium
21 Oct 2024 //
GLOBENEWSWIRE
Astex Announce Key Data Presentations at the AACR 2024 Annual Meeting
03 Apr 2024 //
GLOBENEWSWIRE
Astex Earns AstraZeneca Milestone for Truqap Approval
20 Nov 2023 //
CONTRACT PHARMA
Taiho and Astex Announce Data Presentations at the 65th ASH Annual Meeting
17 Nov 2023 //
PR NEWSWIRE
Otsuka and Astex announce that the European Commission has approved INAQOVI
19 Sep 2023 //
BUSINESSWIRE
Astex Expands Drug Discovery Collaboration With MSD
09 Aug 2023 //
PRESS RELEASE
Cardiff University and Astex in drug discovery collaboration
13 Feb 2023 //
PHARMATIMES
Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours
31 Dec 2022 //
GLOBENEWSWIRE
EMA accepts application for leukaemia drug from Otsuka and Astex
23 Aug 2022 //
PHARMATIMES
EMA begin Review of Oral Fixed-Dose Combination of Decitabine & Cedazuridine
22 Aug 2022 //
BUSINESSWIRE
Astex`s PIII ASCERTAIN-AML Study of Decitabine+Cedazuridine Met Primary Endpoint
12 May 2022 //
BUSINESSWIRE
EC Grants ODD to Oral Decitabine and Cedazuridine in AML
05 Jan 2022 //
BUSINESSWIRE
Astex Pharmaceuticals reports updated Phase III data of Inqovi for MDS
24 Sep 2021 //
CLINICALTRIALSARENA
Astex Presents OS Data From Phase 3 of INQOVI in MDS and CMML
23 Sep 2021 //
BUSINESSWIRE
Recro Pharma, Astex Enter Drug Development Alliance
18 May 2021 //
CONTRACTPHARMA
Taiho and Astex To Present Data In Myelodysplastic Syndromes at the 62nd ASH
02 Dec 2020 //
PRNEWSWIRE
Taiho Oncology and Astex Pharmaceuticals To Present Data In Myelodysplastic
02 Dec 2020 //
PRNEWSWIRE
Astex Expands Clinical Evaluation of Oral Decitabine and Cedazuridine
28 Oct 2020 //
BIOSPACE
Astex trials of guadecitabine for leukaemia fail to meet primary end point
15 Oct 2020 //
CLINICALTRIALSAENA
Astex & Otsuka Announce Results of Ph 3 ASTRAL-2 and ASTRAL-3 (SGI-110)
14 Oct 2020 //
BUSINESSWIRE
Astex Pharmaceuticals and MD Anderson Announce Strategic Collaboration
08 Sep 2020 //
PRESS RELEASE
Astex Pharmaceuticals Announces That Tolinapant Granted Orphan Drug Designation
01 Sep 2020 //
BIOSPACE
Tolinapant (ASTX660) Granted for the Treatment of T-cell Lymphomas
31 Aug 2020 //
BUSINESSWIRE
Astex`s Inqovi nod gives patients on decitabine a non-IV option
03 Aug 2020 //
FIERCE PHARMA
Astex`s Announces FDA Acceptance for Review of an NDA Cedazuridine & Decitabine
12 Feb 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.